InMed Pharmaceuticals (INM) Exchange Rate Effect (2019 - 2020)
InMed Pharmaceuticals' (INM) quarterly Exchange Rate Effect came in at $367235.0 in Q4 2020, up 62.07% year-on-year from $226587.0 in Q1 2020, and up 187.52% quarter-over-quarter from $127725.0 in Q3 2020.
InMed Pharmaceuticals (INM) Exchange Rate Effect (2019 - 2020) Analysis & Trends
InMed Pharmaceuticals' Exchange Rate Effect history runs 2 years deep, the most recent figure standing at $367235.0 for Q4 2020.
- On a quarterly basis, Exchange Rate Effect rose 62.07% year-over-year to $367235.0 in Q4 2020; TTM through Jun 2021 was $494960.0, a 218.88% increase from a year earlier, with the FY2021 full-year figure at $494960.0, up 218.88% from the prior year.
- Exchange Rate Effect grew to $367235.0 in Q4 2020 per INM's latest filing, from $127725.0 in the prior quarter.
- Across five years, Exchange Rate Effect topped out at $367235.0 in Q4 2020 and bottomed at -$700247.0 in Q1 2020.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Exchange Rate Effect (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 87.22 Bn | 85.35 Bn | - | - |
| 2 | Teva Pharmaceutical Industries | 39.60 Bn | 35.87 Bn | 1.97 Bn | -17.00 Mn |
| 3 | Zoetis | 31.46 Bn | 29.52 Bn | 1.62 Bn | 17.00 Mn |
| 4 | Takeda Pharmaceutical | 26.49 Bn | 22.44 Bn | 4.39 Bn | 7.01 Mn |
| 5 | United Therapeutics | 23.03 Bn | 20.88 Bn | 648.10 Mn | - |
| 6 | Universe Pharmaceuticals | 23.03 Bn | -10.56 Bn | - | - |
| 7 | Viatris | 20.90 Bn | 19.09 Bn | 1.16 Bn | -4.20 Mn |
| 8 | Neurocrine Biosciences | 17.50 Bn | 16.19 Bn | 800.70 Mn | - |
| 9 | Elanco Animal Health | 12.33 Bn | 11.91 Bn | 785.00 Mn | -5.00 Mn |
| 10 | InMed Pharmaceuticals | 307,858.50 | -4.93 Mn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2020 | 367,235.00 |
| Dec 31, 2020 | 367,235.00 |
| Sep 30, 2020 | 127,725.00 |
| Sep 30, 2020 | 127,725.00 |
| Jun 30, 2020 | 265,857.00 |
| Jun 30, 2020 | 265,857.00 |
| Mar 31, 2020 | -700,247.00 |
| Mar 31, 2020 | -700,247.00 |
| Dec 31, 2019 | 226,587.00 |
| Dec 31, 2019 | 226,587.00 |
| Sep 30, 2019 | -208,550.00 |
| Sep 30, 2019 | -208,550.00 |